You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 119 No. 1, January 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE THIRD ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, FORT LAUDERDALE, FLA, MAY 7-10, 1983-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Staphylococcus epidermidis Sepsis in Surgical Patients

Kenneth W. Burchard, MD; Lloyd B. Minor, MD; Gus J. Slotman, MD; Donald S. Gann, MD

Arch Surg. 1984;119(1):96-100.


Abstract

• We examined 58 surgical patients with two or more blood cultures positive for Staphylococcus epidermidis to determine factors associated with risk, mortality, and invasive sepsis. Bacterial sepsis was associated with gastrointestinal (GI) operations, total parenteral nutrition, and a regimen of two or more parenteral antibiotics. Mortality was 46% overall and significantly Increased with age greater than 50 years, GI operations, other gram-positive sepsis, recurrent sepsis (positive blood culture 24 hours or more after the first blood culture), and the presence of organisms sensitive to three or less antibiotics. Antibiotic therapy appropriate for more than 50% of the S epidermidis organisms cultured from each patient resulted in significant reduction in mortality. Staphylococcus epidermidis should be considered a significant pathogen in critically ill surgical patients. Invasive S epidermidis sepsis can be recognized and requires specific antibiotic therapy.

(Arch Surg 1984;119:96-100)



Author Affiliations

From the Department of Surgery, Brown University, and Rhode Island Hospital, Providence.


Footnotes

Accepted for publication Sept 8, 1983.

Read before the Third Annual Meeting of the Surgical Infection Society, Fort Lauderdale, Fla, May 10, 1983.

Reprint requests to Rhode Island Hospital, 593 Eddy St, Providence, RI 02903 (Dr Burchard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stimulation of human neutrophils and monocytes by staphylococcal phenol-soluble modulin
Liles et al.
J. Leukoc. Biol. 2001;70:96-102.
ABSTRACT | FULL TEXT  

An Inflammatory Polypeptide Complex from Staphylococcus epidermidis: Isolation and Characterization
Mehlin et al.
JEM 1999;189:907-918.
ABSTRACT | FULL TEXT  

Lipoproteins inhibit macrophage activation by lipoteichoic acid
Grunfeld et al.
J. Lipid Res. 1999;40:245-252.
ABSTRACT | FULL TEXT  

Coagulase-Negative Staphylococcal Bacteremia: Mortality and Hospital Stay
Martin et al.
ANN INTERN MED 1989;110:9-16.
ABSTRACT  

Wound Complications After Infrainguinal Bypass: Classification, Predisposing Factors, and Management
Johnson et al.
Arch Surg 1988;123:859-862.
ABSTRACT  

Enterococcal Bacteremia in Surgical Patients
Barrall et al.
Arch Surg 1985;120:57-63.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.